Recombinant Human EMMPRIN/CD147 Fc Alexa Fluor® 488 Protein AFG972-020: R&D Systems
CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ | Cellular & Molecular Immunology
CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)
Cureus | Preliminary Study of the Cancer Stem Cells' Biomarker CD147 in Leukoplakia: Dysplasia and Squamous Cell Carcinoma of Oral Epithelial Origin | Article
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement | SpringerLink
Recombinant Human EMMPRIN/CD147 Fc Alexa Fluor® 647 Protein AFR972-020: R&D Systems
EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke - Figure f2 | Aging
N-glycosylation-mediated CD147 accumulation induces cardiac fibrosis in the diabetic heart through ALK5 activation
IJMS | Free Full-Text | The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature
Links between CD147 Function, Glycosylation, and Caveolin-1 | Molecular Biology of the Cell
Frontiers | Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin
Enhanced susceptibility of SARS-CoV-2 spike RBD protein assay targeted by cellular receptors ACE2 and CD147: multivariate data analysis of multisine impedimetric response | Analytical Chemistry | ChemRxiv | Cambridge Open Engage